Clinical Trial Update: Characterisation of the Human Carboxylesterase 1 (CES1) Mutations in Thailand [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update reports on the characterization of Human Carboxylesterase 1 (CES1) mutations in Thailand in the context of metabolic disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Disease

Snippet

Sponsor: University of Oxford | Conditions: Metabolic Disease | Phase 4 | Status: COMPLETED